Medical Science Liaison, Oncology Solid Tumor - Michigan and Chicago Territory Novartis AGMedical Science Liaison, Oncology Solid Tumor - Michigan and Chicago TerritoryMichigan, MIRemote$145,600–$270,400 / yearThe primary responsibility of the MSL is to engage with customers - customer engagements may include but are not limited to: emerging data discussions, clinical trial activities, uncovering barriers in patient journey, understanding market dynamics within their territory, exploration of areas of unmet medical need, pipeline discussions, educating on disease state and product, capturing adverse events, and capturing medical insights through all stages of product lifecycle. Maintain in-depth knowledge of assigned therapeutic area and Novartis compounds to serve as a medical resource to customers and internal colleagues (in accordance with Working Practice Documents).Maintain in-depth knowledge of internal policies and external regulations (e.g., field medical Working Practice Document (WPD), travel policy, expense policy, state and local laws, institutional policies) and how they affect day-to-day responsibilities.
Infusion Registered Nurse - PRN, Per Diem Revival Research Institute, LLCInfusion Registered Nurse - PRN, Per DiemSterling Heights, MIAdditional Qualifications: Expert database and computer skills: Microsoft Office (Word, Excel), Outlook, excellent verbal and written communication skills, ability to work independently and assume responsibility, excellent organizational skills, ability to meet data deadlines and maintain confidentiality. Unique opportunity to make an Impact in the healthcare industry… Revival Research Institute, LLC was established in 2015, and headquartered in the Metro Detroit Region, and has been growing ever since.
Principal Investigator (Psychiatry) Act for HealthPrincipal Investigator (Psychiatry)Garden City, MichiganRisks to research subjects are minimized by using procedures which are consistent with sound research design and which do not unnecessarily expose the subjects to risk; and, whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes; Risks to human research subjects are reasonable in relation to the anticipated benefits (if any) to the individual, and the importance of the knowledge that may be expected to result; Selection of human subjects and patients for research participation is equitable; Individuals are adequately informed of the risks and benefits of research participation and the procedures that will be involved in the research, and that informed consent will be obtained from each prospective human research subject, or his/her legally authorized representative, in accordance with, and to the extent required, by company policies and federal regulations; Informed consent of human research subjects will be obtained in advance of research participation and appropriately documented in accordance with, and to the extent required, by company policies and federal regulations; Where appropriate, there is routine monitoring of the data collected to ensure the safety of human research subjects; The privacy of human research subjects is protected and the confidentiality of data is maintained; Appropriate additional safeguards are included in the study to protect the rights and welfare of human research subjects who are likely to be vulnerable to coercion or undue influence (e.g., children, prisoners, individuals with impaired decision-making capacity, or economically or educationally disadvantaged persons). Maintaining adequate, current, and accurate records of research data, outcomes, and reportable new information to permit an ongoing assessment of the risk/benefit ratio of study participation; Reporting promptly any internal or external adverse event that is considered to be unexpected, serious, and possibly or definitely related to the study; Reporting promptly any significant changes in the risk/benefit of study participation; Ensuring that, in the event a research subject experiences a significant adverse event, every reasonable effort is made to provide the subject with adequate care to correct or alleviate the consequences of the adverse event to the extent possible; Ensuring that human research subjects are kept fully informed of any new information that may affect their willingness to continue to participate in the research study; Ensuring that all listed investigators have the appropriate credentials to conduct the portion of the study in which they are involved and have completed the applicable company required training modules; Ensuring that conduct of the research study adheres to Good Clinical Practice guidelines.
Principal Investigator (Gastroenterology) Act for HealthPrincipal Investigator (Gastroenterology)Garden City, MichiganRisks to research subjects are minimized by using procedures which are consistent with sound research design and which do not unnecessarily expose the subjects to risk; and, whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes; Risks to human research subjects are reasonable in relation to the anticipated benefits (if any) to the individual, and the importance of the knowledge that may be expected to result; Selection of human subjects and patients for research participation is equitable; Individuals are adequately informed of the risks and benefits of research participation and the procedures that will be involved in the research, and that informed consent will be obtained from each prospective human research subject, or his/her legally authorized representative, in accordance with, and to the extent required, by company policies and federal regulations; Informed consent of human research subjects will be obtained in advance of research participation and appropriately documented in accordance with, and to the extent required, by company policies and federal regulations; Where appropriate, there is routine monitoring of the data collected to ensure the safety of human research subjects; The privacy of human research subjects is protected and the confidentiality of data is maintained; Appropriate additional safeguards are included in the study to protect the rights and welfare of human research subjects who are likely to be vulnerable to coercion or undue influence (e.g., children, prisoners, individuals with impaired decision-making capacity, or economically or educationally disadvantaged persons). Maintaining adequate, current, and accurate records of research data, outcomes, and reportable new information to permit an ongoing assessment of the risk/benefit ratio of study participation; Reporting promptly any internal or external adverse event that is considered to be unexpected, serious, and possibly or definitely related to the study; Reporting promptly any significant changes in the risk/benefit of study participation; Ensuring that, in the event a research subject experiences a significant adverse event, every reasonable effort is made to provide the subject with adequate care to correct or alleviate the consequences of the adverse event to the extent possible; Ensuring that human research subjects are kept fully informed of any new information that may affect their willingness to continue to participate in the research study; Ensuring that all listed investigators have the appropriate credentials to conduct the portion of the study in which they are involved and have completed the applicable company required training modules; Ensuring that conduct of the research study adheres to Good Clinical Practice guidelines.
Principal Investigator (Neurology) Act for HealthPrincipal Investigator (Neurology)Garden City, MichiganRisks to research subjects are minimized by using procedures which are consistent with sound research design and which do not unnecessarily expose the subjects to risk; and, whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes; Risks to human research subjects are reasonable in relation to the anticipated benefits (if any) to the individual, and the importance of the knowledge that may be expected to result; Selection of human subjects and patients for research participation is equitable; Individuals are adequately informed of the risks and benefits of research participation and the procedures that will be involved in the research, and that informed consent will be obtained from each prospective human research subject, or his/her legally authorized representative, in accordance with, and to the extent required, by company policies and federal regulations; Informed consent of human research subjects will be obtained in advance of research participation and appropriately documented in accordance with, and to the extent required, by company policies and federal regulations; Where appropriate, there is routine monitoring of the data collected to ensure the safety of human research subjects; The privacy of human research subjects is protected and the confidentiality of data is maintained; Appropriate additional safeguards are included in the study to protect the rights and welfare of human research subjects who are likely to be vulnerable to coercion or undue influence (e.g., children, prisoners, individuals with impaired decision-making capacity, or economically or educationally disadvantaged persons). Maintaining adequate, current, and accurate records of research data, outcomes, and reportable new information to permit an ongoing assessment of the risk/benefit ratio of study participation; Reporting promptly any internal or external adverse event that is considered to be unexpected, serious, and possibly or definitely related to the study; Reporting promptly any significant changes in the risk/benefit of study participation; Ensuring that, in the event a research subject experiences a significant adverse event, every reasonable effort is made to provide the subject with adequate care to correct or alleviate the consequences of the adverse event to the extent possible; Ensuring that human research subjects are kept fully informed of any new information that may affect their willingness to continue to participate in the research study; Ensuring that all listed investigators have the appropriate credentials to conduct the portion of the study in which they are involved and have completed the applicable company required training modules; Ensuring that conduct of the research study adheres to Good Clinical Practice guidelines.
Behavioral Research Assistant-Allergy/Adolescent Medicine Ann & Robert H. Lurie Children's Hospital of ChicagoBehavioral Research Assistant-Allergy/Adolescent MedicineLincoln Park, MI$19.50–$30.23 / hourThe Research Assistant will lead participant recruitment and screening, conduct informed consent and study enrollment, and administer virtual social network interviews using Network Canvas software. The ideal candidate is detail-oriented, comfortable engaging diverse participant populations in a virtual research setting, and able to manage multiple study visits and data collection tasks with fidelity to protocol.
Registered Nurse Case Manager - Contingent - 5 years CM required. Henry Ford HospitalRegistered Nurse Case Manager - Contingent - 5 years CM required.Detroit, MICertifications: Certification in Case Management (CCM) by the Commission for Case Management Certification or Accredited Case Manager (ACM) by the American Case Management Association is required within one year of hire. The Case Manager-RN will collaborate closely with patients, families, healthcare providers, and community resources to optimize patient outcomes and promote efficient resource utilization.
Physician Investigator Opportunities - Multiple Locations Nationwide Headlands ResearchPhysician Investigator Opportunities - Multiple Locations NationwideDetroit, MIThis general interest posting is designed for physicians who may not see a current opening that perfectly aligns with their location or specialty-but who would like to be considered for future Investigator, Sub-Investigator, or Physician leadership opportunities across our growing network of clinical research sites nationwide. Our physicians play a critical role in advancing innovative therapies, improving patient access to clinical trials, and shaping high-quality, patient-centered research environments.
RN Case Manager - Inpatient Case Management - Weekends Only Henry Ford HospitalRN Case Manager - Inpatient Case Management - Weekends OnlyDetroit, MICertifications: Certification in Case Management (CCM) by the Commission for Case Management Certification or Accredited Case Manager (ACM) by the American Case Management Association is required within one year of hire. The Case Manager-RN will collaborate closely with patients, families, healthcare providers, and community resources to optimize patient outcomes and promote efficient resource utilization.
Director Program Operations Leader Regeneron PharmaceuticalsDirector Program Operations LeaderWarren, MI$205,000–$341,600 / yearIn this role, you will lead operational strategy and delivery for complex clinical programs while collaborating with senior leaders, vendors, collaboration partners, and clinical study teams. We are seeking a Director Clinical Trial Management Program Operations Leader to join our Clinical Trial Management team, supporting our clinical development organization in a hybrid work mode.
NewSenior Medical Science Liaison - Hematology - Michigan 6120-Janssen Scientific Affairs Legal EntitySenior Medical Science Liaison - Hematology - MichiganDetroit, MichiganAnalytics Dashboards, Clinical Experience, Clinical Research and Regulations, Competitive Landscape, Consulting, Cross-Functional Collaboration, Customer Centricity, Data-Driven Decision Making, Data Gathering and Analysis, Interpersonal Influence, Medical Affairs, Medical Communications, Medical Compliance, Mentorship, Problem Solving, Relationship Building, Research and Development, Strategic Thinking, Tactical Planning, Technical Credibility • Compliantly collaborate with internal stakeholders including but not limited to MSL field partners, R&D, US as well as Global Medical Affairs teams, clinical operations, and appropriate, role‑defined interactions with Sales and Marketing, by demonstrating a strong understanding of the matrixed environment and contributing objective, forward looking scientific perspectives.
REMS Operations & Implementation Lead (Remote - US) MMSREMS Operations & Implementation Lead (Remote - US)Canton, MIRemoteThis role is responsible for gathering, analyzing, and translating client requirements into detailed business and functional requirements, while coordinating cross-functional projects to ensure compliant REMS websites and technology solutions are delivered on time, and in accordance with regulatory requirements. The REMS Business Analyst serves as the critical liaison between business stakeholders, sponsors, and IT teams to ensure the successful delivery of Risk Evaluation and Mitigation Strategy (REMS) programs and supporting REMS solutions.
Associate Director, Field Medical Affairs - Hematology (OH, MI, KY, IN) Regeneron Pharmaceuticals IncAssociate Director, Field Medical Affairs - Hematology (OH, MI, KY, IN)MI$176,100–$287,300 / yearBuild our future together: As an Associate Director, Field Medical Affairs (Medical Science Liaison) you will engage in the exchange of our scientific data and medical information with KOLs, HCPs, researchers, pharmacists and population-based decision makers. Establishing scientific relationships with investigators and internal Medical Affairs, supporting investigator-initiated study (IIS) concept program.
Senior Manager GCP Quality Regeneron PharmaceuticalsSenior Manager GCP QualityWarren, MI$134,400–$219,200 / yearWe are seeking a Senior Manager, GCP Quality Management - Global Development to join our Global Development Quality team, supporting our global clinical development organisation in a hybrid work model. In this role, you will lead risk-based quality management across clinical trials while collaborating with study teams, clinical functions, contract research organisations, and quality colleagues.
NewSenior Manager, Statistical Programming PTC TherapeuticsSenior Manager, Statistical ProgrammingWarren, Michigan$146,600–$184,600 / yearEnsures timely statistical analyses of clinical data per protocols and Statistical Analysis Plans; either directly or through CRO oversight develops statistical programs and produces programmed outputs used to create integrated scientific reports for clinical trial results. Interacts with CROs involved in data management/analysis activities to ensure that their statistical analyses and resulting outputs are accurate and consistent with the contractually agreed upon deliverables; works with vendor staff to characterize and resolve issues related to data analysis.